Schedule 13D ownership disclosure

PRANA BIOTECHNOLOGY LTD SHS (A

Security class unavailable · CUSIP: Q7739U108

Event date: 2019-04-08

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
809,716,599
Percent of class
57.8100%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001144204-19-020287
Form type
SC 13D
Filer
ALTERITY THERAPEUTICS LTD
CIK
CIK 1131343
Filed
Apr 18, 2019
Reporting period
Apr 08, 2019
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub